Journal
GASTROENTEROLOGY
Volume 161, Issue 3, Pages 785-791Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2021.04.082
Keywords
Pancreatic Cancer; Microenvironment; Genome Dy-namics; Emerging Therapies; Molecular Subtypes
Categories
Funding
- Deutsche Forschungsgemeinschaft [CRU/KFO5002, CRC/SFB1321, 329628492, CRU/KFO325]
Ask authors/readers for more resources
Pancreatic ductal adenocarcinoma poses a major challenge in cancer medicine, necessitating interdisciplinary research to improve patient outcomes. The recent 1st Virtual Gottingen-Munich-Marburg Pancreatic Cancer Meeting aimed to foster scientific exchange and summarize current research and proceedings.
Pancreatic ductal adenocarcinoma remains a major challenge in cancer medicine. Given the increase in incidence and mortality, interdisciplinary research is necessary to translate basic knowledge into therapeutic strategies improving the outcome of patients. On the 4th and 5th of February 2021, three German pancreatic cancer research centers, the Clinical Research Unit 5002 from Gottingen, the Collaborative Research Center 1321 from Munich, and Clinical Research Unit 325 from Marburg organized the 1st Virtual Gottingen-Munich-Marburg Pancreatic Cancer Meeting in order to foster scientific exchange. This report summarizes current research and proceedings presented during that meeting.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
